SAGE Open Medical Case Reports (Oct 2022)

Myxedema heart disease and non-comatose presentation of myxedema: A case report

  • Laura Valenzuela-Vallejo,
  • Lucila Emilse Folleco-Ortiz,
  • David Corredor-Orlandelli,
  • Juan Felipe Aguirre-Ruiz,
  • Nicolas Isaza,
  • Alex Valenzuela-Rincon

DOI
https://doi.org/10.1177/2050313X221130227
Journal volume & issue
Vol. 10

Abstract

Read online

Myxedema coma is an emergency that develops from non-diagnosed or severe hypothyroidism and requires early recognition and management. Cardiac manifestations are uncommon and pose a challenge in the recognition of myxedema coma. We present the case of a 76-year-old male with a history of thyroidectomy secondary to a follicular carcinoma, who presented with dyspnea, generalized edema, drowsiness, disorientation, memory loss, and episodic generalized tonic-clonic seizures. Antiepileptic and diuretic treatment for seizures and heart failure exacerbation did not improve the symptoms. Further blood analysis revealed a thyroid-stimulating hormone and free thyroxine of 163 mUL/L and 0.64 ng/dL, respectively. Treatment with intravenous hydrocortisone and levothyroxine led to progressive clinical improvement. Uncommon clinical manifestations such as cardiac and non-specific neurologic symptoms should be considered as manifestations of myxedema coma. A comatose mental status is not a universal manifestation, and milder symptoms should be considered. An adequate assessment, including diagnostic scores and prompt hormonal supplementation prevents fatal consequences.